SMT202000460T1 - Lattoferrina per il trattamento della ibd associata a invasione batterica - Google Patents

Lattoferrina per il trattamento della ibd associata a invasione batterica

Info

Publication number
SMT202000460T1
SMT202000460T1 SM20200460T SMT202000460T SMT202000460T1 SM T202000460 T1 SMT202000460 T1 SM T202000460T1 SM 20200460 T SM20200460 T SM 20200460T SM T202000460 T SMT202000460 T SM T202000460T SM T202000460 T1 SMT202000460 T1 SM T202000460T1
Authority
SM
San Marino
Prior art keywords
lactoferrin
treatment
bacterial invasion
ibd associated
ibd
Prior art date
Application number
SM20200460T
Other languages
English (en)
Inventor
Carlo Terruzzi
Fabio Terruzzi
Original Assignee
Giellepi S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giellepi S P A filed Critical Giellepi S P A
Publication of SMT202000460T1 publication Critical patent/SMT202000460T1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Botany (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SM20200460T 2013-09-25 2014-09-04 Lattoferrina per il trattamento della ibd associata a invasione batterica SMT202000460T1 (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT001578A ITMI20131578A1 (it) 2013-09-25 2013-09-25 Sostanza e formulazione per il trattamento delle malattie infiammatorie croniche intestinali
PCT/IB2014/064255 WO2015044809A1 (en) 2013-09-25 2014-09-04 Lactoferrin for the treatment of ibd associated with bacterial invasion
EP14781676.3A EP3049102B1 (en) 2013-09-25 2014-09-04 Lactoferrin for the treatment of ibd associated with bacterial invasion

Publications (1)

Publication Number Publication Date
SMT202000460T1 true SMT202000460T1 (it) 2020-09-10

Family

ID=49519039

Family Applications (1)

Application Number Title Priority Date Filing Date
SM20200460T SMT202000460T1 (it) 2013-09-25 2014-09-04 Lattoferrina per il trattamento della ibd associata a invasione batterica

Country Status (12)

Country Link
US (1) US20160206707A1 (it)
EP (1) EP3049102B1 (it)
CN (1) CN105744947A (it)
ES (1) ES2794523T3 (it)
HR (1) HRP20200891T1 (it)
IT (1) ITMI20131578A1 (it)
PL (1) PL3049102T3 (it)
PT (1) PT3049102T (it)
RS (1) RS60357B1 (it)
RU (1) RU2689987C2 (it)
SM (1) SMT202000460T1 (it)
WO (1) WO2015044809A1 (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111110834A (zh) * 2020-02-24 2020-05-08 中国科学院昆明动物研究所 转铁蛋白或过表达转铁蛋白在制备治疗和/或预防溃疡性结肠炎的药物中的应用
CN111166872A (zh) * 2020-02-24 2020-05-19 中国科学院昆明动物研究所 转铁蛋白在制备免疫抑制剂类药物中的应用
US20230190652A1 (en) 2020-04-16 2023-06-22 Dermopartners,S.L. Composition for the treatment of covid-19 and treatment method
JP2024534969A (ja) * 2021-09-10 2024-09-26 ユニヴェルザ ヴィ リュブリャナ ラクトフェリンを含む腸溶性コーティング粒子
CN120718138A (zh) * 2024-03-28 2025-09-30 浙江大学 一种具有强吸铁能力的乳铁蛋白及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000076478A1 (en) * 1999-06-14 2000-12-21 Cosmo S.P.A. Controlled release and taste masking oral pharmaceutical compositions
JP4592041B2 (ja) * 2000-11-24 2010-12-01 株式会社Nrlファーマ 生活の質を改善する新規食品の製造法および用途
KR100979877B1 (ko) * 2001-09-28 2010-09-02 뉴트라슈틱스 인코포레이티드 생물학적 성분의 전달 시스템
JP2006111558A (ja) * 2004-10-14 2006-04-27 Bioserentack Co Ltd 多層構造を有する錠剤状の小腸粘膜付着性経口製剤
WO2007038623A2 (en) * 2005-09-28 2007-04-05 Ventria Bioscience Oral formulation for enteric disorders and/or rehydration
RU2418071C2 (ru) * 2008-11-05 2011-05-10 Государственное образовательное учреждение высшего профессионального образования "Астраханский государственный университет" (АГУ) Способ получения бактериального лактоферрина
US20120171163A1 (en) * 2010-12-29 2012-07-05 Anja Wittke Method for inhibiting a bacterial invasive mechanism using a nutritional composition

Also Published As

Publication number Publication date
RU2016115985A3 (it) 2018-03-05
EP3049102A1 (en) 2016-08-03
ES2794523T3 (es) 2020-11-18
RU2016115985A (ru) 2017-10-30
ITMI20131578A1 (it) 2015-03-26
EP3049102B1 (en) 2020-03-04
RU2689987C2 (ru) 2019-05-30
US20160206707A1 (en) 2016-07-21
WO2015044809A1 (en) 2015-04-02
PT3049102T (pt) 2020-06-01
RS60357B1 (sr) 2020-07-31
PL3049102T3 (pl) 2020-09-07
HRP20200891T1 (hr) 2020-09-18
CN105744947A (zh) 2016-07-06

Similar Documents

Publication Publication Date Title
GB2528196B (en) Multiple-qubit wave-activated controlled gate
IL243225B (en) Autoinjector
IL243224A0 (en) Self-injecting syringe
SG11201604537UA (en) Implantable biosensor
SI3569294T1 (sl) Od napihnjenosti neodvisna žoga z ovojem
DK2948461T3 (en) Compounds and methods for treating bacterial infections
PT3084009T (pt) Lactobacillus salivarius para o tratamento da mastite
GB201304872D0 (en) Treatment
GB2514334B (en) Video processing
PT3049102T (pt) Lactoferrina para o tratamento de ibd associadas a invasão bacteriana
GB2513112B (en) Video sequence processing
GB201305564D0 (en) Microbial control
GB2517280B (en) Coffin
EP3016207A4 (en) Waterproof treatment structure for linear member
GB201307310D0 (en) Treatment
GB2514120B (en) Video processing
GB2514124B (en) Turf Treatment
GB201301722D0 (en) Quantifcation of bacteria
GB201321115D0 (en) Treatment
GB201309238D0 (en) Treatment
PT2861214T (pt) Lipossomas adaptados para o tratamento de infeções bacterianas
TWM475460U (en) Microorganism resourcization treatment device
AU2013900784A0 (en) Treatment
HU4376U (en) Closing structure with magnet
GB201317487D0 (en) Bruise control